The Oswaldo Cruz Foundation is the new member of the International Consortium for Personalized Medicine (ICPerMed). Fiocruz is the first Latin American institution to join the consortium, which brings together more than 30 public and private health financing and research agencies from European countries and partners. The office of the Vice President of Education, Information and Communication, in charge of Manoel Barral-Netto, will be responsible for this partnership. tem
The organization aims to support research in personalized medicine that can bring benefits to health systems and citizens. Personalized medicine is an interdisciplinary field of health that seeks to analyze and cross diverse data of individuals available today such as molecular profiles, medical images and lifestyles to tailor the precise and timely treatment for each person or to determine predispositions to diseases and provide timely and targeted prevention.